A Comparative Analysis of Clinical Outcomes in Gingival Recession Treatment: VISTA Technique Alone Versus VISTA Technique Combined with Platelet-Rich Fibrin (PRF)

Comparative evaluation of Vestibular Incision Subperiosteal Tunnel access(VISTA) technique alone and in combination with platelet rich fibrin(PRF) for the treatment of multiple gingival recessions - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059413

Enrollment

Registered

2023-11-02

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: VISTA Technique: Vestibular incision subperiosteal access tunnel technique will be performed to treat patients with millers class I multiple gingival recessions and will be recalled for

Eligibility

Inclusion criteria

Inclusion criteria: 1)At least 2 recession- type defects affecting adjacent teeth with Class ? or class ?? miller’s recession defects. 2)Recession depths = 1mm. 3)Probing depth 4)Presence of identifiable CEJ. 5)Patient willing to give written informed consent.

Exclusion criteria

Exclusion criteria: 1)General contraindications to surgery. 2)Individuals with unacceptable oral hygiene. 3)Patients with active periodontal disease or systemic diseases or pregnancy. 4)Patients taking medications or having treatment with an effect on mucosal healing. 5)Patient who participated in clinical trial within past 6 months.

Design outcomes

Primary

Measure	Time frame
Reduction of gingival marginal recession depthTimepoint: Baseline to 6 months	—

Secondary

Measure	Time frame
NONETimepoint: NONE	—

Countries

India

Contacts

Public ContactDr. Purushottam Rakhewar

SMBT Dental college and Hospital

drpsrakhewar@gmail.com9370017343

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026